Evidence-Based Recommendations for Seizure Prophylaxis in Patients with Brain Metastases Undergoing Stereotactic Radiosurgery

Acta Neurochir Suppl. 2021:128:51-55. doi: 10.1007/978-3-030-69217-9_6.

Abstract

Symptomatic epilepsy is frequently encountered in patients with brain metastases (BM), affecting up to 25% of them. However, it generally remains unknown whether the risk of seizures in such cases is affected by stereotactic radiosurgery (SRS), which involves highly conformal delivery of high-dose irradiation to the tumor with a minimal effect on adjacent brain tissue. Thus, the role of prophylactic administration of antiepileptic drugs (AED) after SRS remains controversial. A comprehensive review and analysis of the available literature reveals that according to prospective studies, the incidence of seizures after SRS for BM varies from 8% to 22%, and there is no evidence that SRS increases the incidence of symptomatic epilepsy. Therefore, routine prophylactic administration of AED prior to, during, or after SRS in the absence of a seizure history is not recommended. Nevertheless, short-course administration of an AED may be judiciously considered (on the basis of class III evidence) for selected high-risk individuals.

Keywords: Antiepileptic drugs; Fractionated radiotherapy; Intracranial metastases; Prophylactic antiepileptic therapy; Seizures; Stereotactic radiosurgery; Symptomatic epilepsy.

Publication types

  • Review

MeSH terms

  • Brain Neoplasms* / surgery
  • Humans
  • Prospective Studies
  • Radiosurgery*
  • Retrospective Studies
  • Seizures / etiology
  • Seizures / prevention & control